Get the Stockscreener App
3.67
0.55%
0.02
After Hours:
3.69
0.02
+0.54%
Bionano Genomics Inc stock is traded at $3.67, with a volume of 38,476.
It is up +0.55% in the last 24 hours and down -11.57% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$3.65
Open:
$3.62
24h Volume:
38,476
Relative Volume:
0.28
Market Cap:
$12.33M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.2064
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-1.34%
1M Performance:
-11.57%
6M Performance:
-76.07%
1Y Performance:
-93.71%
1-Day Range:
$3.57
$3.7721
1-Week Range:
$3.57
$3.87
52-Week Range:
$2.68
$60.60
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
3.67 | 12.51M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
552.34 | 193.38B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.59 | 49.12B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.94 | 42.79B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.79 | 35.61B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.50 | 15.46B | 11.89B | -560.00M | 191.00M | -1.10 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
How To Trade (BNGO) - news.stocktradersdaily.com
Bionano Genomics stock rises on Q1 revenue beat - MSN
Bionano Genomics, Inc. (NASDAQ:BNGO) Given Average Rating of “Hold” by Analysts - Defense World
Bionano Genomics (NASDAQ:BNGO) Stock Rating Upgraded by Wall Street Zen - Defense World
Maxim Group Upgrades Bionano Genomics (NASDAQ:BNGO) to Buy - Defense World
Maxim Group Upgrades Bionano Genomics (BMV:BNGO) - Nasdaq
Maxim Group Upgrades Bionano Genomics (LSE:0A4K) - Nasdaq
Maxim Group Upgrades Bionano Genomics (BNGO) - Nasdaq
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upg - GuruFocus
Bionano Genomics (BNGO) Receives Buy Rating and Price Target Upgrade | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brig - GuruFocus
Bionano Genomics (BNGO) Upgraded to Buy as Future Prospects Brighten | BNGO Stock News - GuruFocus
Maxim Upgrades Bionano Genomics to Buy From Hold, $8 Price Target - marketscreener.com
Bionano (BNGO) Achieves Milestone with New CPT Code for Genetic - GuruFocus
(BNGO) Long Term Investment Analysis - news.stocktradersdaily.com
Bionano Laboratories Announces a Second Category I CPT Code - GlobeNewswire
Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders - Yahoo Finance
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2025 Earnings Call Transcript - Insider Monkey
Biggest stock movers Thursday: UNH, CSCO, NTES, FL, BABA, and more - MSN
Biggest stock movers Thursday: CSCO, FL, BABA, BNGO, and more - MSN
Biggest stock movers Thursday: CSCO, BNGO, and more - MSN
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - The Manila Times
Bionano Genomics Q1 2025 Earnings Call Transcript - MarketBeat
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 202 - GuruFocus
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall - Asianet Newsable
Bionano Genomics (BNGO) Refocuses Strategy Amid Revenue Dip - GuruFocus
Bionano outlines $26M–$30M 2025 revenue target as strategic pivot drives higher gross margin - MSN
Earnings call transcript: Bionano Genomics Q1 2025 sees revenue drop, stock surges - Investing.com
Bionano Genomics (BNGO) Sees Strategic Shift Boost in Q1 2025 | - GuruFocus
Bionano Genomics Q1 2025 Earnings: Revenue Beats Estimates at $6 - GuruFocus
Bionano Genomics stock rises on Q1 revenue beat (BNGO:NASDAQ) - Seeking Alpha
BNGO Stocks Projected to Install Up to 20 New OGM Systems in 2025 | BNGO Stock News - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected - GuruFocus
Bionano Genomics (BNGO) Forecasts Lower Q2 Revenue Than Expected | BNGO Stock News - GuruFocus
Bionano Genomics Q1 2025 Financial Results - TradingView
A Glimpse of Bionano Genomics's Earnings Potential - Nasdaq
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study - GuruFocus
Bionano Genomics (BNGO) Boosts Cancer Diagnostics with New Study Findings | BNGO Stock News - GuruFocus
Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies - The Manila Times
Bionano Laboratories Announces Publication of the Largest - GlobeNewswire
Bionano Genomics (BNGO) Projected to Post Earnings on Wednesday - The AM Reporter
Bionano Genomics (BNGO) to Release Quarterly Earnings on Wednesday - Defense World
When (BNGO) Moves Investors should Listen - news.stocktradersdaily.com
Renaissance Technologies LLC Takes Position in Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - The Manila Times
Geode Capital Management LLC Acquires 114,822 Shares of Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):